A Randomized, Double-blind, Placebo-controlled Study of Ranolazine in Patients With Heart Failure With Preserved Ejection Fraction.
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2013
At a glance
- Drugs Ranolazine (Primary) ; Ranolazine (Primary)
- Indications Diastolic heart failure
- Focus Therapeutic Use
- Acronyms RALI-DHF
- 10 Jun 2017 Biomarkers information updated
- 14 Apr 2012 New source identified and integrated (European Clinical Trials Database EudraCT2009-017168-17).
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History